HEADER VIRAL PROTEIN 08-OCT-23 8WOZ TITLE CRYO-EM STRUCTURE OF SARS-COV RBD IN COMPLEX WITH RABBIT ACE2 COMPND MOL_ID: 1; COMPND 2 MOLECULE: ANGIOTENSIN-CONVERTING ENZYME; COMPND 3 CHAIN: A; COMPND 4 EC: 3.4.-.-; COMPND 5 ENGINEERED: YES; COMPND 6 MOL_ID: 2; COMPND 7 MOLECULE: SPIKE PROTEIN S1; COMPND 8 CHAIN: B; COMPND 9 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: ORYCTOLAGUS CUNICULUS; SOURCE 3 ORGANISM_COMMON: RABBIT; SOURCE 4 ORGANISM_TAXID: 9986; SOURCE 5 GENE: ACE2; SOURCE 6 EXPRESSION_SYSTEM: HOMO SAPIENS; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 9606; SOURCE 8 MOL_ID: 2; SOURCE 9 ORGANISM_SCIENTIFIC: SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS; SOURCE 10 ORGANISM_COMMON: SARS-COV; SOURCE 11 ORGANISM_TAXID: 694009; SOURCE 12 GENE: S, 2; SOURCE 13 EXPRESSION_SYSTEM: HOMO SAPIENS; SOURCE 14 EXPRESSION_SYSTEM_TAXID: 9606 KEYWDS SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS, ANGIOTENSIN-CONVERTING KEYWDS 2 ENZYME 2 (PROTEIN), RABBIT, VIRAL PROTEIN EXPDTA ELECTRON MICROSCOPY AUTHOR L.J.LI,K.Y.SHI,G.H.YU,G.F.GAO REVDAT 3 28-FEB-24 8WOZ 1 JRNL REVDAT 2 03-JAN-24 8WOZ 1 JRNL REVDAT 1 13-DEC-23 8WOZ 0 JRNL AUTH K.SHI,L.LI,C.LUO,Z.XU,B.HUANG,S.MA,K.LIU,G.YU,G.F.GAO JRNL TITL STRUCTURAL BASIS OF INCREASED BINDING AFFINITIES OF SPIKES JRNL TITL 2 FROM SARS-COV-2 OMICRON VARIANTS TO RABBIT AND HARE ACE2S JRNL TITL 3 REVEALS THE EXPANDING HOST TENDENCY. JRNL REF MBIO V. 15 98823 2024 JRNL REFN ESSN 2150-7511 JRNL PMID 38112468 JRNL DOI 10.1128/MBIO.02988-23 REMARK 2 REMARK 2 RESOLUTION. 3.25 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 SOFTWARE PACKAGES : PHENIX REMARK 3 RECONSTRUCTION SCHEMA : NULL REMARK 3 REMARK 3 EM MAP-MODEL FITTING AND REFINEMENT REMARK 3 PDB ENTRY : NULL REMARK 3 REFINEMENT SPACE : NULL REMARK 3 REFINEMENT PROTOCOL : NULL REMARK 3 REFINEMENT TARGET : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE : NULL REMARK 3 REMARK 3 FITTING PROCEDURE : NULL REMARK 3 REMARK 3 EM IMAGE RECONSTRUCTION STATISTICS REMARK 3 NOMINAL PIXEL SIZE (ANGSTROMS) : NULL REMARK 3 ACTUAL PIXEL SIZE (ANGSTROMS) : NULL REMARK 3 EFFECTIVE RESOLUTION (ANGSTROMS) : 3.250 REMARK 3 NUMBER OF PARTICLES : 94460 REMARK 3 CTF CORRECTION METHOD : PHASE FLIPPING AND AMPLITUDE REMARK 3 CORRECTION REMARK 3 REMARK 3 EM RECONSTRUCTION MAGNIFICATION CALIBRATION: NULL REMARK 3 REMARK 3 OTHER DETAILS: NULL REMARK 4 REMARK 4 8WOZ COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBC ON 11-OCT-23. REMARK 100 THE DEPOSITION ID IS D_1300041696. REMARK 245 REMARK 245 EXPERIMENTAL DETAILS REMARK 245 RECONSTRUCTION METHOD : SINGLE PARTICLE REMARK 245 SPECIMEN TYPE : NULL REMARK 245 REMARK 245 ELECTRON MICROSCOPE SAMPLE REMARK 245 SAMPLE TYPE : PARTICLE REMARK 245 PARTICLE TYPE : POINT REMARK 245 NAME OF SAMPLE : CRYO-EM STRUCTURE OF SARS-COV REMARK 245 RBD IN COMPLEX WITH RABBIT ACE2 REMARK 245 SAMPLE CONCENTRATION (MG ML-1) : NULL REMARK 245 SAMPLE SUPPORT DETAILS : NULL REMARK 245 SAMPLE VITRIFICATION DETAILS : NULL REMARK 245 SAMPLE BUFFER : NULL REMARK 245 PH : 8.00 REMARK 245 SAMPLE DETAILS : NULL REMARK 245 REMARK 245 DATA ACQUISITION REMARK 245 DATE OF EXPERIMENT : NULL REMARK 245 NUMBER OF MICROGRAPHS-IMAGES : NULL REMARK 245 TEMPERATURE (KELVIN) : NULL REMARK 245 MICROSCOPE MODEL : FEI TITAN KRIOS REMARK 245 DETECTOR TYPE : GATAN K3 (6K X 4K) REMARK 245 MINIMUM DEFOCUS (NM) : 1000.00 REMARK 245 MAXIMUM DEFOCUS (NM) : 2000.00 REMARK 245 MINIMUM TILT ANGLE (DEGREES) : NULL REMARK 245 MAXIMUM TILT ANGLE (DEGREES) : NULL REMARK 245 NOMINAL CS : NULL REMARK 245 IMAGING MODE : BRIGHT FIELD REMARK 245 ELECTRON DOSE (ELECTRONS NM**-2) : 6000.00 REMARK 245 ILLUMINATION MODE : OTHER REMARK 245 NOMINAL MAGNIFICATION : NULL REMARK 245 CALIBRATED MAGNIFICATION : NULL REMARK 245 SOURCE : FIELD EMISSION GUN REMARK 245 ACCELERATION VOLTAGE (KV) : 300 REMARK 245 IMAGING DETAILS : NULL REMARK 247 REMARK 247 ELECTRON MICROSCOPY REMARK 247 THE COORDINATES IN THIS ENTRY WERE GENERATED FROM ELECTRON REMARK 247 MICROSCOPY DATA. PROTEIN DATA BANK CONVENTIONS REQUIRE REMARK 247 THAT CRYST1 AND SCALE RECORDS BE INCLUDED, BUT THE VALUES REMARK 247 ON THESE RECORDS ARE MEANINGLESS EXCEPT FOR THE CALCULATION REMARK 247 OF THE STRUCTURE FACTORS. REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 HIS A 615 REMARK 465 HIS A 616 REMARK 465 HIS A 617 REMARK 465 HIS A 618 REMARK 465 HIS A 619 REMARK 465 HIS A 620 REMARK 465 ARG B 306 REMARK 465 VAL B 307 REMARK 465 VAL B 308 REMARK 465 PRO B 309 REMARK 465 SER B 310 REMARK 465 GLY B 311 REMARK 465 ASP B 312 REMARK 465 VAL B 313 REMARK 465 VAL B 314 REMARK 465 ARG B 315 REMARK 465 PHE B 316 REMARK 465 PRO B 317 REMARK 465 ASN B 318 REMARK 465 ILE B 319 REMARK 465 THR B 320 REMARK 465 ASN B 321 REMARK 465 LEU B 322 REMARK 465 CYS B 323 REMARK 465 PRO B 324 REMARK 465 PHE B 325 REMARK 465 GLY B 326 REMARK 465 GLU B 327 REMARK 465 VAL B 328 REMARK 465 PHE B 501 REMARK 465 GLU B 502 REMARK 465 LEU B 503 REMARK 465 LEU B 504 REMARK 465 ASN B 505 REMARK 465 ALA B 506 REMARK 465 PRO B 507 REMARK 465 ALA B 508 REMARK 465 THR B 509 REMARK 465 VAL B 510 REMARK 465 CYS B 511 REMARK 465 GLY B 512 REMARK 465 PRO B 513 REMARK 465 LYS B 514 REMARK 465 LEU B 515 REMARK 465 SER B 516 REMARK 465 THR B 517 REMARK 465 ASP B 518 REMARK 465 LEU B 519 REMARK 465 ILE B 520 REMARK 465 LYS B 521 REMARK 465 ASN B 522 REMARK 465 GLN B 523 REMARK 465 CYS B 524 REMARK 465 VAL B 525 REMARK 465 ASN B 526 REMARK 465 PHE B 527 REMARK 465 HIS B 528 REMARK 465 HIS B 529 REMARK 465 HIS B 530 REMARK 465 HIS B 531 REMARK 465 HIS B 532 REMARK 465 HIS B 533 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 LYS A 78 52.52 -92.26 REMARK 500 THR A 129 40.55 -102.91 REMARK 500 GLN A 135 -7.37 74.13 REMARK 500 SER A 136 -163.45 -162.77 REMARK 500 LEU A 143 -147.27 56.53 REMARK 500 ASP A 292 52.19 30.46 REMARK 500 THR A 296 -13.71 73.07 REMARK 500 SER A 602 -147.51 63.29 REMARK 500 PHE A 603 25.10 46.57 REMARK 500 VAL B 404 -50.91 -124.98 REMARK 500 LYS B 465 76.15 53.59 REMARK 500 PRO B 470 49.89 -95.43 REMARK 500 REMARK 500 REMARK: NULL REMARK 620 REMARK 620 METAL COORDINATION REMARK 620 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 620 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 ZN A 701 ZN REMARK 620 N RES CSSEQI ATOM REMARK 620 1 HIS A 374 NE2 REMARK 620 2 HIS A 378 NE2 94.6 REMARK 620 3 GLU A 402 OE1 116.3 75.9 REMARK 620 N 1 2 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: EMD-37703 RELATED DB: EMDB REMARK 900 CRYO-EM STRUCTURE OF SARS-COV RBD IN COMPLEX WITH RABBIT ACE2 DBREF 8WOZ A 19 614 UNP G1TEF4 G1TEF4_RABIT 19 614 DBREF 8WOZ B 306 527 UNP P59594 SPIKE_SARS 306 527 SEQADV 8WOZ HIS A 615 UNP G1TEF4 EXPRESSION TAG SEQADV 8WOZ HIS A 616 UNP G1TEF4 EXPRESSION TAG SEQADV 8WOZ HIS A 617 UNP G1TEF4 EXPRESSION TAG SEQADV 8WOZ HIS A 618 UNP G1TEF4 EXPRESSION TAG SEQADV 8WOZ HIS A 619 UNP G1TEF4 EXPRESSION TAG SEQADV 8WOZ HIS A 620 UNP G1TEF4 EXPRESSION TAG SEQADV 8WOZ HIS B 528 UNP P59594 EXPRESSION TAG SEQADV 8WOZ HIS B 529 UNP P59594 EXPRESSION TAG SEQADV 8WOZ HIS B 530 UNP P59594 EXPRESSION TAG SEQADV 8WOZ HIS B 531 UNP P59594 EXPRESSION TAG SEQADV 8WOZ HIS B 532 UNP P59594 EXPRESSION TAG SEQADV 8WOZ HIS B 533 UNP P59594 EXPRESSION TAG SEQRES 1 A 602 SER THR ILE GLU GLU LEU ALA LYS THR PHE LEU GLU LYS SEQRES 2 A 602 PHE ASN GLN GLU ALA GLU ASP LEU SER TYR GLN SER ALA SEQRES 3 A 602 LEU ALA SER TRP ASP TYR ASN THR ASN ILE THR GLU GLU SEQRES 4 A 602 ASN VAL GLN LYS MET ASN ASP ALA GLU ALA LYS TRP SER SEQRES 5 A 602 ALA PHE TYR GLU GLU GLN SER LYS LEU ALA LYS THR TYR SEQRES 6 A 602 PRO SER GLN GLU VAL GLN ASN LEU THR VAL LYS ARG GLN SEQRES 7 A 602 LEU GLN ALA LEU GLN GLN SER GLY SER SER ALA LEU SER SEQRES 8 A 602 ALA ASP LYS SER LYS GLN LEU ASN THR ILE LEU SER THR SEQRES 9 A 602 MET SER THR ILE TYR SER THR GLY LYS VAL CYS ASN GLN SEQRES 10 A 602 SER ASN PRO GLN GLU CYS PHE LEU LEU GLU PRO GLY LEU SEQRES 11 A 602 ASP GLU ILE MET ALA LYS SER THR ASP TYR ASN GLU ARG SEQRES 12 A 602 LEU TRP ALA TRP GLU GLY TRP ARG SER VAL VAL GLY LYS SEQRES 13 A 602 GLN LEU ARG PRO LEU TYR GLU GLU TYR VAL VAL LEU LYS SEQRES 14 A 602 ASN GLU MET ALA ARG ALA ASN ASN TYR GLU ASP TYR GLY SEQRES 15 A 602 ASP TYR TRP ARG ALA ASP TYR GLU ALA GLU GLY ALA ASP SEQRES 16 A 602 GLY TYR ASP TYR SER ARG SER GLN LEU ILE ASP ASP VAL SEQRES 17 A 602 GLU ARG THR PHE SER GLU ILE LYS PRO LEU TYR GLU GLN SEQRES 18 A 602 LEU HIS ALA PHE VAL ARG THR LYS LEU MET ASP ALA TYR SEQRES 19 A 602 PRO SER ARG ILE SER PRO THR GLY CYS LEU PRO ALA HIS SEQRES 20 A 602 LEU LEU GLY ASP MET TRP GLY ARG PHE TRP THR ASN LEU SEQRES 21 A 602 TYR SER LEU THR VAL PRO PHE GLY GLN LYS PRO ASN ILE SEQRES 22 A 602 ASP VAL THR ASP THR MET VAL ASN GLN GLY TRP ASP ALA SEQRES 23 A 602 GLU ARG ILE PHE LYS GLU ALA GLU LYS PHE PHE VAL SER SEQRES 24 A 602 VAL GLY LEU PRO SER MET THR GLN GLY PHE TRP GLU ASN SEQRES 25 A 602 SER MET LEU THR GLU PRO GLY ASP GLY ARG LYS VAL VAL SEQRES 26 A 602 CYS HIS PRO THR ALA TRP ASP LEU GLY LYS GLY ASP PHE SEQRES 27 A 602 ARG ILE LYS MET CYS THR LYS VAL THR MET ASP ASN PHE SEQRES 28 A 602 LEU THR ALA HIS HIS GLU MET GLY HIS ILE GLN TYR ASP SEQRES 29 A 602 MET ALA TYR ALA THR GLN PRO PHE LEU LEU ARG ASN GLY SEQRES 30 A 602 ALA ASN GLU GLY PHE HIS GLU ALA VAL GLY GLU ILE MET SEQRES 31 A 602 SER LEU SER ALA ALA THR PRO GLU HIS LEU LYS SER ILE SEQRES 32 A 602 GLY LEU LEU PRO TYR ASP PHE HIS GLU ASP ASN GLU THR SEQRES 33 A 602 GLU ILE ASN PHE LEU LEU LYS GLN ALA LEU THR ILE VAL SEQRES 34 A 602 GLY THR LEU PRO PHE THR TYR MET LEU GLU LYS TRP ARG SEQRES 35 A 602 TRP MET VAL PHE LYS GLY GLU ILE PRO LYS GLU GLN TRP SEQRES 36 A 602 MET GLN LYS TRP TRP GLU MET LYS ARG GLU ILE VAL GLY SEQRES 37 A 602 VAL VAL GLU PRO MET PRO HIS ASP GLU THR TYR CYS ASP SEQRES 38 A 602 PRO ALA ALA LEU PHE HIS VAL ALA ASN ASP TYR SER PHE SEQRES 39 A 602 ILE ARG TYR TYR THR ARG THR ILE TYR GLN PHE GLN PHE SEQRES 40 A 602 GLN GLU ALA LEU CYS GLN ALA ALA GLN HIS GLU GLY PRO SEQRES 41 A 602 LEU HIS LYS CYS ASP ILE SER ASN SER THR GLU ALA GLY SEQRES 42 A 602 GLN LYS LEU LEU ASN MET LEU ARG LEU GLY ARG SER GLU SEQRES 43 A 602 PRO TRP THR LEU ALA LEU GLU ASN VAL VAL GLY ALA LYS SEQRES 44 A 602 ASN MET ASP VAL ARG PRO LEU LEU ASN TYR PHE GLU PRO SEQRES 45 A 602 LEU PHE THR TRP LEU LYS GLU GLN ASN ARG ASN SER PHE SEQRES 46 A 602 VAL GLY TRP SER THR GLU TRP THR PRO TYR ALA HIS HIS SEQRES 47 A 602 HIS HIS HIS HIS SEQRES 1 B 228 ARG VAL VAL PRO SER GLY ASP VAL VAL ARG PHE PRO ASN SEQRES 2 B 228 ILE THR ASN LEU CYS PRO PHE GLY GLU VAL PHE ASN ALA SEQRES 3 B 228 THR LYS PHE PRO SER VAL TYR ALA TRP GLU ARG LYS LYS SEQRES 4 B 228 ILE SER ASN CYS VAL ALA ASP TYR SER VAL LEU TYR ASN SEQRES 5 B 228 SER THR PHE PHE SER THR PHE LYS CYS TYR GLY VAL SER SEQRES 6 B 228 ALA THR LYS LEU ASN ASP LEU CYS PHE SER ASN VAL TYR SEQRES 7 B 228 ALA ASP SER PHE VAL VAL LYS GLY ASP ASP VAL ARG GLN SEQRES 8 B 228 ILE ALA PRO GLY GLN THR GLY VAL ILE ALA ASP TYR ASN SEQRES 9 B 228 TYR LYS LEU PRO ASP ASP PHE MET GLY CYS VAL LEU ALA SEQRES 10 B 228 TRP ASN THR ARG ASN ILE ASP ALA THR SER THR GLY ASN SEQRES 11 B 228 TYR ASN TYR LYS TYR ARG TYR LEU ARG HIS GLY LYS LEU SEQRES 12 B 228 ARG PRO PHE GLU ARG ASP ILE SER ASN VAL PRO PHE SER SEQRES 13 B 228 PRO ASP GLY LYS PRO CYS THR PRO PRO ALA LEU ASN CYS SEQRES 14 B 228 TYR TRP PRO LEU ASN ASP TYR GLY PHE TYR THR THR THR SEQRES 15 B 228 GLY ILE GLY TYR GLN PRO TYR ARG VAL VAL VAL LEU SER SEQRES 16 B 228 PHE GLU LEU LEU ASN ALA PRO ALA THR VAL CYS GLY PRO SEQRES 17 B 228 LYS LEU SER THR ASP LEU ILE LYS ASN GLN CYS VAL ASN SEQRES 18 B 228 PHE HIS HIS HIS HIS HIS HIS HET ZN A 701 1 HETNAM ZN ZINC ION FORMUL 3 ZN ZN 2+ HELIX 1 AA1 THR A 20 ASN A 53 1 34 HELIX 2 AA2 GLU A 57 LYS A 78 1 22 HELIX 3 AA3 LEU A 79 TYR A 83 5 5 HELIX 4 AA4 ASN A 90 GLN A 102 1 13 HELIX 5 AA5 GLY A 104 LEU A 108 5 5 HELIX 6 AA6 SER A 109 THR A 129 1 21 HELIX 7 AA7 GLY A 147 SER A 155 1 9 HELIX 8 AA8 ASP A 157 ASN A 194 1 38 HELIX 9 AA9 ASP A 198 ALA A 205 1 8 HELIX 10 AB1 ASP A 206 GLU A 208 5 3 HELIX 11 AB2 SER A 218 SER A 220 5 3 HELIX 12 AB3 GLN A 221 LYS A 247 1 27 HELIX 13 AB4 HIS A 265 LEU A 267 5 3 HELIX 14 AB5 TRP A 275 TYR A 279 5 5 HELIX 15 AB6 THR A 296 GLY A 301 1 6 HELIX 16 AB7 ASP A 303 SER A 317 1 15 HELIX 17 AB8 THR A 324 SER A 331 1 8 HELIX 18 AB9 THR A 365 TYR A 385 1 21 HELIX 19 AC1 PRO A 389 ARG A 393 5 5 HELIX 20 AC2 GLY A 399 GLY A 405 1 7 HELIX 21 AC3 GLY A 405 ALA A 413 1 9 HELIX 22 AC4 THR A 414 GLY A 422 1 9 HELIX 23 AC5 ASP A 431 VAL A 447 1 17 HELIX 24 AC6 THR A 449 GLY A 466 1 18 HELIX 25 AC7 PRO A 469 GLU A 471 5 3 HELIX 26 AC8 GLN A 472 ILE A 484 1 13 HELIX 27 AC9 CYS A 498 ALA A 502 5 5 HELIX 28 AD1 LEU A 503 ASN A 508 1 6 HELIX 29 AD2 ILE A 513 ALA A 533 1 21 HELIX 30 AD3 SER A 547 ARG A 559 1 13 HELIX 31 AD4 PRO A 565 GLY A 575 1 11 HELIX 32 AD5 VAL A 581 PHE A 588 1 8 HELIX 33 AD6 PHE A 588 ASN A 599 1 12 HELIX 34 AD7 TYR B 352 TYR B 356 5 5 HELIX 35 AD8 THR B 372 LEU B 377 5 6 HELIX 36 AD9 LYS B 390 ILE B 397 5 8 SHEET 1 AA1 2 LEU A 262 PRO A 263 0 SHEET 2 AA1 2 VAL A 487 VAL A 488 1 O VAL A 488 N LEU A 262 SHEET 1 AA2 2 THR A 347 GLY A 352 0 SHEET 2 AA2 2 ASP A 355 LYS A 359 -1 O LYS A 359 N THR A 347 SHEET 1 AA3 5 GLU B 341 ILE B 345 0 SHEET 2 AA3 5 VAL B 382 VAL B 389 -1 O VAL B 382 N ILE B 345 SHEET 3 AA3 5 TYR B 494 SER B 500 -1 O TYR B 494 N VAL B 389 SHEET 4 AA3 5 CYS B 419 ASN B 424 -1 N LEU B 421 O VAL B 497 SHEET 5 AA3 5 THR B 363 CYS B 366 -1 N THR B 363 O ALA B 422 SHEET 1 AA4 2 LYS B 439 ARG B 441 0 SHEET 2 AA4 2 LEU B 478 ASP B 480 -1 O ASN B 479 N TYR B 440 SSBOND 1 CYS A 344 CYS A 361 1555 1555 2.03 SSBOND 2 CYS A 530 CYS A 542 1555 1555 2.03 SSBOND 3 CYS B 366 CYS B 419 1555 1555 2.03 SSBOND 4 CYS B 467 CYS B 474 1555 1555 2.03 LINK NE2 HIS A 374 ZN ZN A 701 1555 1555 2.30 LINK NE2 HIS A 378 ZN ZN A 701 1555 1555 2.01 LINK OE1 GLU A 402 ZN ZN A 701 1555 1555 2.60 CISPEP 1 PRO B 469 PRO B 470 0 3.58 CRYST1 1.000 1.000 1.000 90.00 90.00 90.00 P 1 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 1.000000 0.000000 0.000000 0.00000 SCALE2 0.000000 1.000000 0.000000 0.00000 SCALE3 0.000000 0.000000 1.000000 0.00000